Skip to main content
. 2019 Mar 6;123(2):238–245. doi: 10.1016/j.bja.2019.01.032

Table 1.

Patient characteristics and co-morbidities as risk factors for death at 90 days

All patients (n=1375) Survivors (n=1334) Non-survivors (n=41) P-value
Age (median, IQR) 72 (65–79) 72 (65–78) 76 (70–83) 0.004
Anaerobic threshold (median, IQR) 11.2 (9.6–13.0) 11.2 (9.6–13.0) 10.9 (9.1–12.1) 0.27
VE/VCO2 (median, IQR) 33 (30–38) 33 (30–37) 39 (32–43) <0.001
Potential demographic risk factors
All patients (risk factor present/absent), n/N (%) 90-day mortality (%) Unadjusted odds ratio (95% CI) Adjusted odds ratio (95% CI)
Risk factor No risk factor
Male sex 813/562 (59.1) 3.8 1.8 2.19 (1.06–4.50) 2.44 (1.17–5.09)
Cancer spread 519/856 (37.7) 3.1 2.9 1.06 (0.56–2.00) N/A
Open surgery 1083/292 (78.8) 3.1 2.4 1.32 (0.55–3.30) N/A
Age 80 yr or older (Y/N) 243/1131 (17.7) 6.6 2.2 3.12 (1.64–5.93) 2.18 (1.10–4.32)
VE/VCO2 >39 245/1130 (17.8) 8.2 1.9 4.69 (2.50–8.80) 4.04 (2.09–7.84)
Potential clinical co-morbidity risk factors
All patients (risk factor present/absent), n/N (%) 90-day mortality (%) Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Risk factor No risk factor
Ischaemic heart disease 189/1186 (13.7) 5.3 2.6 2.08 (1.00–4.31) 1.61 (0.76–3.41)
Heart failure 24/1351 (1.7) 4.2 3.0 1.42 (0.19–10.8) N/A
Cerebrovascular disease 78/1297 (5.7) 2.6 3.0 0.85 (0.20–3.58) N/A
Diabetes mellitus (any) 164/1211 (11.9) 3.7 2.9 1.28 (0.52–3.08) N/A
Renal insufficiency 50/1325 (3.6) 12.0 2.6 5.03 (2.01–12.6) N/A
COPD 86/1289 (6.3) 8.1 2.6 3.27 (1.40–7.61) N/A
Asthma 82/1293 (6.0) 0.0 3.2 0.97 (0.96–0.98) N/A
Other lung disease 53/1322 (3.9) 5.7 2.9 2.03 (0.60–0.96) N/A

Excluded from binary logistic regression as less than 10 events in some cells. CI, confidence interval; COPD, chronic obstructive pulmonary disease; IQR, inter-quartile range; N/A, not available; VE/VCO2, ratio of minute ventilation (L min–1) to carbon dioxide excretion (mL kg–1 min–1)